Long Acting Uses, Dosage, Side Effects and more
Long Acting has been used in trials studying the prevention and treatment of Haemophilia A, Haemophilia B, Congenital Bleeding Disorder, Haemophilia B With Inhibitors, and Haemophilia A With Inhibitors.
| Trade Name | Long Acting |
| Generic | Eptacog alfa pegol (activated) |
| Eptacog alfa pegol (activated) Other Names | Activated Recombinant Human Factor VII, Long Acting, Eptacog alfa pegol (activated) |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
